3-吡啶脒肟，CAS 登记号 1594-58-7，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 3-吡啶脒肟 的 CAS 号：1594-58-7，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
3-PYRIDYLAMIDOXIME · CAS 1594-58-7 · C6H7N3O. UNII NS00015524.
| CAS Registry Number | 1594-58-7 |
|---|---|
| PubChem CID | 308113 |
| Molecular formula | C6H7N3O |
| IUPAC name | N'-hydroxypyridine-3-carboximidamide |
| UNII (FDA) | NS00015524 |
| Molecular Weight | 137.14 |
|---|---|
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 137.058911855 |
| Monoisotopic Mass | 137.058911855 |
| Topological Polar Surface Area | 71.5 |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Reported hazard statements | H315 (100%), H319 (100%), H335 (97.8%) |
|---|
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
1594-58-7; N-Hydroxynicotinimidamide; 3-Pyridylamidoxime; N-hydroxypyridine-3-carboximidamide; N'-Hydroxy-3-pyridinecarboximidamide; N'-hydroxynicotinimidamide; Nicotinamidoxime; Nicotinamide oxime; 1217433-56-1; MFCD00125875; N-Hydroxynicotinamidine; n-hydroxy-nicotinamidine; Pyridine-3-carboxamide oxime; 3-pyridinamidoxime; 3-Pyridinecarboxamidoxime; N-hydroxy-nicotinimidamide
CAS 1594-58-7; molecular formula C6H7N3O; molecular weight — g/mol.
1594-58-7, N-Hydroxynicotinimidamide, 3-Pyridylamidoxime, N-hydroxypyridine-3-carboximidamide, N'-Hydroxy-3-pyridinecarboximidamide, N'-hydroxynicotinimidamide.
Hazard statements reported: H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.